Claseprubart
Based on 1 Customer Validation
Claseprubart (DNTH103) is an inhibitor targeting C1s of the complement system and an inhibitor of the C1 component of the complement cascade. Claseprubart is in phase 2 clinical evaluation. Claseprubart has application potential in research related to multifocal motor neuropathy and generalized myasthenia gravis.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza : 99%
- No. CAS: 2922766-89-8
- Peso molecular:144.638 kDa
-
Almacenamiento:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
Isotype
Human IgG4 kappa
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
Complement C1s
In Vitro
Co-incubation of DNTH103 (0.1 μM, 1 μM) with complement-containing serum from AChR-positive myasthenia gravis patients significantly reduces the muscle contraction fatigue index and improves neuromuscular transmission function in a human iPSC-derived motor neuron-muscle cell co-culture myasthenia gravis model. Its efficacy is superior to that of anti-C5 antibody at the same concentration, and it exerts no significant effect on serum samples from healthy individuals[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Gene ID
Accession
Conjugated
Unconjugated
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
IgG4-kappa
Aplicación
ELISA, FACS, Functional assay
Verified Bioactivity
-
Loaded Claseprubart on ProA biosensor, can bind HY-P700696 C1s/Complement C1s Protein, Human (HEK293, His) with an affinity constant of 3.648E-09 M as determined in BLI assay.
Chemical Information
-
No. CAS 2922766-89-8
-
Appearance Liquid
-
Peso molecular 144.638 kDa
-
Color Colorless to light yellow
-
SMILES
[Claseprubart]
-
Synonyms
DNTH103
-
Envío
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
-
Ficha de datos (258 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)